Posted by Michael Wonder on 27 Jul 2017
£3 a day drug for irritable bowel syndrome gets NICE approval
27 July 2017 - The drug, Truberzi has been recommended for routine funding on the NHS to treat patients with irritable bowel syndrome and diarrhoea.
Truberzi, also known as eluxadoline, made by Allergan will be routinely available for patients who have not responded or are cannot take other treatments.
This drug works by binding to certain receptors in the digestive system, to slow down the movement of food through the gut. This helps to relieve associated stomach cramps and the urgency for a person to go to the toilet.
